company background image
ACW

Actinogen Medical ASX:ACW Stock Report

Last Price

AU$0.025

Market Cap

AU$56.4m

7D

13.6%

1Y

-78.3%

Updated

02 Dec, 2023

Data

Company Financials +

ACW Stock Overview

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.

ACW fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Actinogen Medical Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Actinogen Medical
Historical stock prices
Current Share PriceAU$0.025
52 Week HighAU$0.12
52 Week LowAU$0.015
Beta2.22
1 Month Change56.25%
3 Month Change0%
1 Year Change-78.26%
3 Year Change19.05%
5 Year Change-48.98%
Change since IPO-96.95%

Recent News & Updates

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Nov 16
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Recent updates

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Nov 16
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Aug 02
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

Apr 12
We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Nov 28
We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Aug 09
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Apr 07
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Oct 24
We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

Jul 11
Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

Mar 27
We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Jan 07
How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Shareholder Returns

ACWAU BiotechsAU Market
7D13.6%2.1%0.5%
1Y-78.3%-13.3%-3.4%

Return vs Industry: ACW underperformed the Australian Biotechs industry which returned -13.3% over the past year.

Return vs Market: ACW underperformed the Australian Market which returned -3.4% over the past year.

Price Volatility

Is ACW's price volatile compared to industry and market?
ACW volatility
ACW Average Weekly Movement14.7%
Biotechs Industry Average Movement13.2%
Market Average Movement8.8%
10% most volatile stocks in AU Market17.7%
10% least volatile stocks in AU Market3.1%

Stable Share Price: ACW is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: ACW's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
1999n/aSteve Gourlayhttps://www.actinogen.com.au

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, depression with cognitive impairment, Alzheimer’s disease, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015.

Actinogen Medical Limited Fundamentals Summary

How do Actinogen Medical's earnings and revenue compare to its market cap?
ACW fundamental statistics
Market CapAU$56.35m
Earnings (TTM)-AU$10.75m
Revenue (TTM)AU$4.89m

11.5x

P/S Ratio

-5.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ACW income statement (TTM)
RevenueAU$4.89m
Cost of RevenueAU$0
Gross ProfitAU$4.89m
Other ExpensesAU$15.64m
Earnings-AU$10.75m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.0048
Gross Margin100.00%
Net Profit Margin-219.98%
Debt/Equity Ratio0%

How did ACW perform over the long term?

See historical performance and comparison